<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The emergence of multidrug-resistant (MDR) microorganisms represents a global challenge worldwide, since therapeutic options are limited, resulting in thousands of deaths [
 <xref rid="B1-molecules-23-02584" ref-type="bibr" class="xref">1</xref>]. Furthermore, there is a paucity of novel and effective antimicrobial agents in the pipeline, especially against carbapenem-resistant (CR) 
 <italic class="italic">Acinetobacter baumannii</italic> and CR 
 <italic class="italic">Enterobacteriaceae</italic> carrying enzymes other than class A carbapenemases [
 <xref rid="B2-molecules-23-02584" ref-type="bibr" class="xref">2</xref>].
</p>
